The Eurasian Patent Office (EAPO) received applications from the states of Europe and Southeast Asia.
The Eurasian Patent Organization (EAPO) has opened accounts in IDBank, Republic of Armenia. Funds can be transferred in Armenian drams, US dollars and euros.
The President of the Eurasian Patent Office spoke at the final Rospatent press conference "How the landscape of the intellectual property market in Russia has changed: 2022 results". Grigory Ivliev noted the achievements of the Russian office in the field of digital transformation and spoke on the joint activities of the EAPO and Rospatent in the Eurasian space.
Eurasian Court Jurisdiction – a natural step towards improving the procedures for contesting Eurasian patents
European and Asian Law Review, a scientific information and educational journal covering current issues of law science and practice of the EAEC, BRICS and SCO member states, published an article by EAPO President Grigory Ivliev (in English).
Key features of the Eurasian patent procedure and advantages of electronic interaction with the Eurasian Patent Office were presented in details.
The Eurasian Patent Office held a webinar on advanced digital tools of the World Intellectual Property Organization (WIPO) – WIPO CASE and WIPO DAS.
President of the Eurasian Patent Office Grigory Ivliev delivered a lecture to the students of the Third School of Foreign Law, traditionally held at the Kutafin Moscow State Law University.
Register of Eurasian Patent Attorneys
Information for Patent Attorneys
System of electronic filing and electronic document exchange
Official publication that provides access to current descriptions of Eurasian applications and patents, including data from the initial publication, notices of changes in legal status and current claims of inventions
The system provides multi-aspect search and access to the world patent Fund, including the Russian-language array of patent documentation of the Eurasian region
Information and search resource providing information on Eurasian patents, conversion to pharmacologically active substances, their legal status in the EAPC member states, as well as on registered medicines